Scarica l'app Stockscreener
0.334
3.77%
-0.0131
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
What analysts say about bioAffinity Technologies Inc. stockExtraordinary profit generation - PrintWeekIndia
What analysts say about bioAffinity Technologies Inc. Equity Warrant stockSuperior profit margins - PrintWeekIndia
bioAffinity Technologies Approves Key Proposals at Annual Meeting - TipRanks
Is bioAffinity Technologies Inc. Equity Warrant stock a good hedge against inflationHigh-velocity capital appreciation - jammulinksnews.com
What institutions are buying bioAffinity Technologies Inc. stock nowConsistent triple returns - jammulinksnews.com
When is the best time to buy bioAffinity Technologies Inc. Equity Warrant stockMarket-beating returns - jammulinksnews.com
Will bioAffinity Technologies Inc. stock benefit from interest rate changesSkyrocketing investment returns - jammulinksnews.com
What drives bioAffinity Technologies Inc. stock priceDynamic growth stocks - Autocar Professional
bioAffinity’s CyPath® Lung Test Identifies Missed Tumor - TipRanks
Breakthrough: New Lung Cancer Test Catches Hidden Stage 1A Tumor Other Diagnostics Missed - Stock Titan
The BIAF Stock Puzzle: Unraveling BioAffinity Technologies Inc’s Fluctuating Performance - investchronicle.com
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentHigh-yield investments - jammulinksnews.com
Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic - BioSpace
bioAffinity Technologies obtains Canadian patent for lung cancer spit test - Mugglehead Magazine
bioAffinity Technologies Inc. Stock Analysis and ForecastOver 200% growth - jammulinksnews.com
Is bioAffinity Technologies Inc. a good long term investmentLightning-fast capital gains - jammulinksnews.com
What drives bioAffinity Technologies Inc. Equity Warrant stock priceExceptional risk-adjusted gains - jammulinksnews.com
bioAffinity Technologies Secures Canadian Patent for Lung Cancer Detection - TipRanks
Published on: 2025-07-22 10:16:37 - Newser
bioAffinity Technologies secures Canadian patent for lung cancer test By Investing.com - Investing.com India
bioAffinity Technologies Inc. Equity Warrant Stock Analysis and ForecastBreakout profit opportunities - jammulinksnews.com
1.50%
1.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):